UCSF studies video risk assessment for primary care physicians
University of California San Francisco
Give to UCSF
Thanks to a recent UCSF graduate, the pharmacy care needs of the deaf and hard-of-hearing community are now coming through loud and clear.
Mary Anne Koda-Kimble, dean of the UCSF School of Pharmacy, will be honored by the American Pharmaceutical Association next month.
As plans for the Mission Bay campus take shape, so too do the plans for what to do with laboratory space that will become available at Parnassus.
Philip Morris tobacco company launched a hidden campaign in the 1990s to change the standards of scientific proof needed to demonstrate that secondhand smoke was dangerous...
The smoking rate could be cut dramatically across the U.S. if political will is applied to do it. In California, the rate could be cut to ten percent in just five years, according to an analysis by University of California, San Francisco researchers.
A recent study at the University of California, San Francisco assessed specialists' attitudes toward primary care physicians in the gatekeeper role, finding the attitudes are influenced by practice settings and by financial interests that may be threatened by referral restrictions.
A UCSF-led team is reporting striking results in mice that indicate that a molecule known as HIF-1 could prove an effective target for inducing the growth of blood vessels in oxygen-starved tissues.
People who care for their frail elderly relatives instead of putting them in nursing homes frequently miss work or leave their jobs entirely, according to research from San Francisco VA Medical Center (SFVAMC).
In a discovery that demonstrates a clear link between the mind and body at a molecular level, scientists have shown that a chemical signal which normally allows nerve cells to communicate with each other - to alter sleep cycles, for example -- can also re-direct actions of the immune system.
SAN DIEGO -- Women who have a particular gene sequence are at a higher risk of developing cognitive impairment and Alzheimer's disease, according to a study from researchers at UCSF and the Veterans Affairs Medical Center (SFVAMC).
At a time when harmful drug reactions are thought to rank just after strokes as a leading cause of death in the U.S., the potential benefits of tailoring drugs to a patient's genetic makeup have been confirmed in a systematic study led by University of California, San Francisco scientists.